ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tandospirone. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

22 träffar

Bibliografisk träff 2019-12-01

Retraction Note to: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.

Natsui K, Mizuno Y, Tani N, Yabuki M, Komuro S.

Eur J Drug Metab Pharmacokinet · journal article; retraction notice · DOI 10.1007/s13318-019-00585-5

Bibliografisk träff 2019-09-05

Effect of Tandospirone, a Partial Agonist of the 5-HT1A Receptor, in a Patient With Chronic Poststroke Emotional Incontinence With Anxiousness.

Tamura T, Shiwaku H, Jitoku D, Kurumaji A.

Prim Care Companion CNS Disord · journal article; case reports · DOI 10.4088/pcc.18l02403

Bibliografisk träff 2019-04-22

Simultaneous determination of tandospirone and its active metabolite, 1-[2-pyrimidyl]-piperazine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.

Hu W, Jia M, He S, Xie H, Jiang X, Wang L.

Biomed Chromatogr · journal article · DOI 10.1002/bmc.4525

Bibliografisk träff 2019-03-01

Dose-Dependent Efficacy of Tandospirone for an Oldest-Old Patient With Behavioral and Psychological Symptoms of Dementia.

Ochi S, Mori T, Iga JI, Ueno SI.

J Clin Psychopharmacol · letter; case reports · DOI 10.1097/jcp.0000000000000998

Bibliografisk träff 2018-11-01

Tandospirone-Induced Rhabdomyolysis.

Miyazaki K, Otaka M, Yasui-Furukori N.

Clin Neuropharmacol · journal article; case reports · DOI 10.1097/wnf.0000000000000303

Bibliografisk träff 2018-02-10

Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.

Lin J, Su Y, Wang C, Yang F, Xu Y, Yuan Y, Yuan Y, Wang X, Yu X, Si T.

J Psychiatr Res · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.jpsychires.2018.01.020

Bibliografisk träff 2017-10-27

Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Huang X, Yang J, Yang S, Cao S, Qin D, Zhou Y, Li X, Ye Y, Wu J.

Oncotarget · review-article; review; journal article · DOI 10.18632/oncotarget.22170

Bibliografisk träff 2015-04-03

Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.

Murata Y, Yanagihara Y, Mori M, Mine K, Enjoji M.

J Affect Disord · journal article · DOI 10.1016/j.jad.2015.03.054

Bibliografisk träff 2015-03-21

The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.

Baba S, Murai T, Nakako T, Enomoto T, Ono M, Shimizu I, Ikeda K.

Behav Brain Res · journal article · DOI 10.1016/j.bbr.2015.03.025

Bibliografisk träff 2015-01-01

Effects of the 5-HT(1A) Receptor Agonist Tandospirone on ACTH-Induced Sleep Disturbance in Rats.

Tsutsui R, Shinomiya K, Sendo T, Kitamura Y, Kamei C.

Biol Pharm Bull · comparative study; journal article · DOI 10.1248/bpb.b14-00887

Bibliografisk träff 2014-08-01

Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Lan L, Chen YL, Zhang H, Jia BL, Chu YJ, Wang J, Tang SX, Xia GD.

World J Gastroenterol · research-article; multicenter study; randomized controlled trial; journal article · DOI 10.3748/wjg.v20.i32.11422

Bibliografisk träff 2013-10-12

Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.

Elkina Y, Palus S, Tschirner A, Hartmann K, von Haehling S, Doehner W, Mayer U, Coats AJ, Beadle J, Anker SD, Springer J.

Int J Cardiol · journal article · DOI 10.1016/j.ijcard.2013.10.022

Bibliografisk träff 2010-07-31

Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats.

Bubenikova-Valesova V, Svoboda J, Horacek J, Sumiyoshi T.

Psychopharmacology (Berl) · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/s00213-010-1951-3

Tillbakadragen publikation 2007-07-01

Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.

Natsui K, Mizuno Y, Tani N, Yabuki M, Komuro S.

Eur J Drug Metab Pharmacokinet · retracted publication; journal article · DOI 10.1007/bf03190475

Bibliografisk träff 1990-07-01

Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites.

Hamik A, Oksenberg D, Fischette C, Peroutka SJ.

Biol Psychiatry · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/0006-3223(90)90627-e

Bibliografisk träff 1990-03-01

Autoradiographic evidence for the interaction of SM-3997 with 5-HT1A receptors in the rat brain.

Tanaka H, Shimizu H, Tatsuno T, Hirose A, Kumasaka Y, Nakamura M.

Jpn J Pharmacol · journal article · DOI 10.1254/jjp.52.504

Bibliografisk träff 1990-03-01

The clinical efficacy of a 5-HT1A agonist, SM-3997, in the treatment of bulimia.

Tamai H, Komaki G, Kubota S, Kobayashi N, Matsubayashi S, Mori K, Nakagawa T, Takayama T, Kimura M, Kumagai LF.

Int J Obes · journal article

Bibliografisk träff 1990-01-01

Pharmacology of the serotonergic anxiolytic tandospirone (SM-3997).

Seymour PA, Mena EE, McLean S, Heym J.

Prog Clin Biol Res · review; journal article

Bibliografisk träff 1989-04-01

Effects of the putative anxiolytic SM-3997 on central monoaminergic systems.

Tatsuno T, Shimizu H, Hirose A, Tanaka H, Kumasaka Y, Nakamura M.

Pharmacol Biochem Behav · journal article · DOI 10.1016/0091-3057(89)90079-8

Bibliografisk träff 1988-03-01

Interaction of SM-3997 with serotonin receptors in rat brain.

Shimizu H, Karai N, Hirose A, Tatsuno T, Tanaka H, Kumasaka Y, Nakamura M.

Jpn J Pharmacol · journal article · DOI 10.1254/jjp.46.311

Bibliografisk träff 1988-01-01

Characterization of the putative anxiolytic SM-3997 recognition sites in rat brain.

Shimizu H, Tatsuno T, Hirose A, Tanaka H, Kumasaka Y, Nakamura M.

Life Sci · comparative study; journal article · DOI 10.1016/0024-3205(88)90340-2

Bibliografisk träff 1987-12-01

Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate.

Shimizu H, Hirose A, Tatsuno T, Nakamura M, Katsube J.

Jpn J Pharmacol · journal article · DOI 10.1254/jjp.45.493